• Printer Friendly
  • Text Resizer - Small
  • Text Resizer - Large
  • Email this page

NPS Pharmacy Practice Reviews

Our pharmacy practice reviews are free quality improvement activities that help pharmacists and intern pharmacists to review their current practice for patients with certain conditions compared to current best practice standards, guidelines and pharmacist competencies.


Current Pharmacy Practice Reviews

Title

Date

Reducing CVD risk (online activity)

Available from January 2012
Register NOW

Find out more

 

Previous Pharmacy Practice Reviews

Sample packs of past activities.

Title
Date
Reducing CVD risk  (paper-based activity)

2011 - Closed

Optimal use of opioid-containing analgesics in chronic pain

2010 - Closed
Quality use of prescription PPIs
2009 - Closed

Enhancing patient care in type 2 diabetes 

2008 – Closed

Medication management in hypertension

2007 – Closed

Optimising the use of OTC analgesics

2006 – Closed

Quality use of inhaled medicines in COPD

2006 – Closed

Drug use in type 2 diabetes

2005 – Closed

Quality use of antidepressants

2005 – Closed

Management of depression 

2004 – Closed

Self-audit for pharmacists on OTC-NSAIDs

2004 – Closed

Osteoporosis and calcium supplements

2003 – Closed

Dyspepsia in community pharmacy

2003 – Closed

Smoking cessation

2002 – Closed

Managing the common cold

2002 – Closed

Provision of OTC NSAIDs

2002 – Closed

About pharmacy practice reviews

Pharmacy practice reviews use best practice standards and guidelines to help pharmacists review current practice, consider implementing changes to practice, review and reflect on these changes, and monitor progress.

Review materials also focus on identifying priorities for patient counselling, provide tools to assist effective counselling and identify pharmacist competencies which will be addressed by completion of the activity.

All participants complete data collection for 10 patients, receive a feedback report that includes individual results, aggregate results of all participants' practices and an expert commentary on the aggregate results. Participants are provided with a template to record their development and learning plan.

One pharmacy practice review is available each year, with two opportunities to complete the activity.

Qualifying for CPD points

This activity has been accredited for 8 hours of Group 2 CPD
(or 16 CPD credits) suitable for inclusion in an individual pharmacist's CPD plan.
Accredited PSA activity
 

Recognition for continuing professional development

For information about recording continuing professional development, see About points, incentives and QPI

Pharmacy practice reviews assist pharmacists to meet the following competency standards as set out in the Pharmaceutical Society of Australia Competency Standards for Pharmacists in Australia 2010:

Standard 1.2 Practise to accepted standards

Standard 1.3 Deliver ‘patient-centred’ care

Standard 1.5 Maintain and extend professional competence

Standard 2.1 Communicate effectively

Standard 2.2 Work to resolve problems

Standard 2.3 Collaborate with members of the health care team

Standard 3.4 Manage quality service delivery

Standard 4.2 Consider the appropriateness of prescribed medicines

Standard 4.3 Dispense prescribed medicines

Standard 6.1 Assess primary health care needs

Standard 6.2 Deliver primary health care

Standard 6.3 Contribute to public and preventive health

Standard 7.1 Contribute to therapeutic decision-making

Standard 7.3 Influence patterns of medicine use

Date published: 2008-02-12 00:00:00

Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.

References to brands should not be taken as an endorsement by NPS.